|
Editorial · Éditorial |
95 |
Understanding autism a work in progress P.E. Tanguay [full text] |
|
|
Commentary · Commentaire |
97 |
Transcranial magnetic stimulation: using a law of physics to treat psychopathology G.M. Hasey [full text] |
|
|
Review Papers · Examens critiques |
103 |
Etiology of infantile autism: a review of recent advances in genetic and neurobiological research G. Trottier, L. Srivastava, C.-D. Walker [full text / résumé] |
116 |
Assessing the machinery of mind: synapses in neuropsychiatric disorders W.G. Honer [abstract / résumé] |
|
|
Research Papers · Articles de recherche |
122 |
Discriminative stimulus properties of indorenate, a serotonin agonist D.N. Velázquez-Martinez, M. López Cabrera, H. Sánchez, J.I. Ramírez, E. Hong [abstract / résumé] |
131 |
Computed tomographic findings in schizophrenia: relation with symptom dimensions and sex differences A.K. Malla, J. Takhar, R.M.G. Norman, L. Assis [abstract / résumé] |
|
Special section: Pharmacogenics · Section spéciale sur la pharmacogénétique |
|
|
Editorial · Éditorial |
139 |
Pharmacogenetic research: a revolutionary science W. Kalow [full text] |
|
|
Research Paper · Article de recherche |
141 |
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability R. Joober, C. Benkelfat, K. Brisebois, A. Toulouse, G. Turecki, S. Lal, D. Bloom, A. Labelle, P. Lalonde, D. Fortin, M. Alda, R. Palmour, G.A. Rouleau [abstract / résumé] |
|
|
Review Papers · Examens critiques |
147 |
Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease J. Poirier [abstract / résumé] |
154 |
Pharmacogenetics of lithium response in bipolar disorder M. Alda [abstract / résumé] |
159 |
Heterogeneity and the genetics of autism P. Szatmari [abstract / résumé] |
|
166 |
Book Reviews · Recensions |
192 |
Psychopharmacology for the Clinician · Psychopharmacologie pratique |